1. Home
  2. Publications
  1. Home
  2. Publications

Filters

Research Groups

Core Facilities

Start date
End date

Figure S7 from <i>In Vivo</i> Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade
Authors: CYC Lee, I Dean, N Richoz, Z Li, BC Kennedy, LA Vettore, Y Samarakoon, KL G...
Research group: Halim Group
E-pub date: 2 Sep 2025
Journal name:

Figure S5 from <i>In Vivo</i> Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade
Authors: CYC Lee, I Dean, N Richoz, Z Li, BC Kennedy, LA Vettore, Y Samarakoon, KL G...
Research group: Halim Group
E-pub date: 2 Sep 2025
Journal name:

Data from <i>In Vivo</i> Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade
Authors: CYC Lee, I Dean, N Richoz, Z Li, BC Kennedy, LA Vettore, Y Samarakoon, KL G...
Research group: Halim Group
E-pub date: 2 Sep 2025
Journal name:

Growth kinetics of high-grade serous ovarian cancer: implications for early detection.
Authors: B Narayanan, T Buddenkotte, H Smith, M Shah, S Freeman, D Hulse, G Funingan...
Research group: Brenton Group
E-pub date: 1 Sep 2025
Journal name: Br J Cancer

Transcript Identification Using Arrayed Hydrogels With TrapFISH
Authors: DB Morse, Z Toprakcioglu, A Denduluri‐Marthi, JD Brenton, CJ Thomas, TPJ ...
Research group: Brenton Group
E-pub date: 1 Sep 2025
Journal name: Advanced Materials Technologies

Multi-task deep learning for automatic image segmentation and treatment response assessment in metastatic ovarian cancer.
Authors: B Drury, IP Machado, Z Gao, T Buddenkotte, G Mahani, G Funingana, M Reinius...
Research group: Brenton Group
E-pub date: 1 Sep 2025
Journal name: Int J Comput Assist Radiol Surg

Transcript Identification Using Arrayed Hydrogels With TrapFISH (Adv. Mater. Technol. 18/2025)
Authors: DB Morse, Z Toprakcioglu, A Denduluri‐Marthi, JD Brenton, CJ Thomas, TPJ ...
Research group: Brenton Group
E-pub date: 1 Sep 2025
Journal name: Advanced Materials Technologies

1064O ICON8B: GCIG phase III randomised trial comparing first-line weekly dose-dense chemotherapy + bevacizumab to three-weekly chemotherapy + bevacizumab in high-risk stage III-IV epithelial ovarian cancer (EOC): Final overall survival (OS) analysis
Authors: AR Clamp, I McNeish, D Radice, R Lord, A Michael, A Cook, R Agarwal, A Walt...
Research group: Brenton Group
E-pub date: 1 Sep 2025
Journal name: Annals of Oncology